BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35836512)

  • 1. Increase of CD3
    Huang Z; Chen B; Ling Y; Pan Y; Jiang S; Zhang S; Yu K; Han Y
    Transl Cancer Res; 2022 Jun; 11(6):1463-1471. PubMed ID: 35836512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
    Schwonzen M; Pohl C; Steinmetz T; Wickramanayake PD; Thiele J; Diehl V
    Br J Haematol; 1992 Jul; 81(3):362-9. PubMed ID: 1382545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
    Porwit-MacDonald A; Björklund E; Lucio P; van Lochem EG; Mazur J; Parreira A; van den Beemd MW; van Wering ER; Baars E; Gaipa G; Biondi A; Ciudad J; van Dongen JJ; San Miguel JF; Orfao A
    Leukemia; 2000 May; 14(5):816-25. PubMed ID: 10803512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Relevance of Bone Marrow Microenvironment Components in Non Hodgkin’s Lymphoma Cases Before and After Therapy.
    Soliman AH
    Asian Pac J Cancer Prev; 2016 Dec; 17(12):5273-5280. PubMed ID: 28125873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.
    Dehghani M; Sharifpour S; Amirghofran Z; Zare HR
    Med Oncol; 2012 Dec; 29(4):2364-71. PubMed ID: 22307765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.
    Tembhare PR; Chatterjee G; Chaturvedi A; Dasgupta N; Khanka T; Verma S; Ghogale SG; Deshpande N; Girase K; Sengar M; Bagal B; Jain H; Shetty D; Rajpal S; Patkar N; Agrawal T; Epari S; Shet T; Subramanian PG; Gujral S
    Front Oncol; 2022; 12():779230. PubMed ID: 35299754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma.
    Uckun FM; Song CW; Nesbit M; Kersey JH; Ramsay NK
    Int J Radiat Oncol Biol Phys; 1992; 24(4):705-12. PubMed ID: 1429095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
    Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
    J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of bone marrow cells in non-Hodgkin's lymphoma by DNA analysis.
    Chen PM; Fan S; Lin SH; Tzeng CH; Liu JH; Liu JM; Yeh HM; Chiou TJ
    Leuk Res; 1991; 15(12):1097-106. PubMed ID: 1662735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell associated antigen-positive B-cell lymphoma.
    Inaba T; Shimazaki C; Sumikuma T; Nakagawa M
    Leuk Lymphoma; 2001; 42(6):1161-71. PubMed ID: 11911397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and Prognosis Value of Bone Marrow Aspirate Detection for the Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients].
    Gao F; Ke XY; Wang J; Zhu MX; Hu K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):488-494. PubMed ID: 32319384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma].
    Song W; Xie Y; Deng L; Shi Y; Li X; Zheng W; Wang X; Lin N; Tu M; Ying Z; Ping L; Liu W; Zhang C; Ding N; Song Y; Zhu J
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):2996-3000. PubMed ID: 25547702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
    Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
    J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
    Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
    Biomark Res; 2020; 8():6. PubMed ID: 32082573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.